Microbiome Associations in Multiple Sclerosis
Research indicates that gut microbial dysbiosis in multiple sclerosis (MS) may be linked to impaired intestinal barrier function, immune dysregulation, and altered host metabolic signaling. Specific microbial communities and their metabolites, such as short-chain fatty acids, might play regulatory roles in these processes.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
Understanding the relationship between gut microbiota and MS could lead to insights for future diagnostic and therapeutic strategies, emphasizing the gut-brain axis's role in disease pathology.
What this does not prove
Causal relationships have not yet been established, and the current evidence remains primarily associative, necessitating further investigation.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-26
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceDeconstructing the microbiota-gut-brain axis in multiple sclerosis: from a barrier-immune-metabolic framework to emerging therapeutics. ↗DOI: 10.1016/j.msard.2026.107948
Supporting passages (5)
publication date2026-09-26
interventionmicrobiome-targeted interventions
findingsGut microbial dysbiosis in MS is associated with impaired intestinal barrier function, immune dysregulation, and altered host metabolic signaling.
limitationsEmerging evidence from additional microbial niches, including the oral microbiome, further supports a broader microbial ecosystem perspective on MS immunopathology, although causal relationships remain to be established.
limitationsEmerging multi-omics studies suggest potential regulatory roles of specific microbial communities, including ileal taxa, alongside core host signaling targets such as Caspase 3 (CASP3) and E1A binding protein p300 (EP300), although evidence remains largely associative.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.